The rise of GLP-1 drugs like Ozempic are changing consumer food waste patterns both at home and in restaurant settings.

A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases ...

New York’s reputation as a trailblazer for health equity is in danger. We must ensure equity in obesity treatment.

As the old saying goes, “an ounce of prevention is worth a pound of cure,” and in my decades of experience in healthcare that ...

In countless reports and studies, obesity is often reduced to just a number: 42% of adults in the U.S. have obesity, ...

A new University of Michigan study shows that a strong majority of older Americans want health insurance — including Medicare — to cover weight loss medica ...

Dr Harriet Treacy, co-founder of Beyondbmi, spoke with EVOKE to explain that obesity is a disease that requires medical treatment, whereas many people are simply availing of the drugs to lose a few ...

Fashion influencer Remi Bader just revealed she underwent a weight loss surgery that cut 80 percent of her stomach amid ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

A Prime Therapeutics analysis of real-world data has found that medical costs for patients taking GLP-1 drugs for obesity had increased by about $1,338 per member, compared with a matched control ...

A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases in life expectancy and disease-free years while generating a ...